CGTN published this video item, entitled “China grants market approval for recombinant COVID-19 vaccine” – below is their description.
For more:
China’s drug regulator the National Medical Products Administration approved on Thursday the registration application of a domestically produced recombinant COVID-19 vaccine. Led by Chen Wei, a researcher at the Academy of Military Sciences, a team developed a vaccine with the modified defective adenovirus as the vector. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase III trials.
CGTN YouTube Channel
Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.